BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6982951)

  • 1. Human platelet-immune complex interaction in plasma.
    Clark WF; Tevaarwerk GJ; Reid BD
    J Lab Clin Med; 1982 Dec; 100(6):917-31. PubMed ID: 6982951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation and release associated with immune complex formation in pig plasma.
    Clark WF; Tevaarwerk GJ; Bandali K; Lindsay RM; Linton AL
    J Lab Clin Med; 1980 Oct; 96(4):654-65. PubMed ID: 7419956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the mechanism of the human platelet release reaction induced by immunologic stimuli. III. Relationship between the binding of soluble IgG aggregates to the Fc receptor and cell response in the presence and absence of plasma.
    Pfueller SL; Weber S; Lüscher EF
    J Immunol; 1977 Feb; 118(2):514-24. PubMed ID: 557068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
    Davis P; Cumming RH; Verrier-Jones J
    Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococci-induced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor.
    Hawiger J; Steckley S; Hammond D; Cheng C; Timmons S; Glick AD; Des Prez RM
    J Clin Invest; 1979 Oct; 64(4):931-7. PubMed ID: 479376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
    Meryhew NL; Kimberly RP; Messner RP; Runquist OA
    J Immunol; 1986 Jul; 137(1):97-102. PubMed ID: 3486919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
    Anderson CL; Stillman WS
    J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody.
    Tron F; Letarte J; Roque-Antunes Barreira MC; Lesavre P
    Clin Exp Immunol; 1982 Aug; 49(2):481-7. PubMed ID: 6982138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
    Horgan C; Burge J; Crawford L; Taylor RP
    J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
    Shido K; Ahmad G; Hsu L; Kamiyama M
    J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-associated DNA and anti-DNA antibody in systemic lupus erythematosus with nephritis.
    Frampton G; Perl S; Bennett A; Cameron JS
    Clin Exp Immunol; 1986 Mar; 63(3):621-8. PubMed ID: 3486735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.
    Atkins KL; Burman JD; Chamberlain ES; Cooper JE; Poutrel B; Bagby S; Jenkins AT; Feil EJ; van den Elsen JM
    Mol Immunol; 2008 Mar; 45(6):1600-11. PubMed ID: 18061675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of T-cell-mediated regulation of antibody production by interaction with specific immune complexes.
    Clough JD; Calabrese LH; Budervic SA
    Clin Lab Med; 1988 Jun; 8(2):337-49. PubMed ID: 3284700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fc-mediated immune precipitation. II. Analysis of precipitating immune complexes by rate-zonal ultracentrifugation.
    Møller NP; Steensgaard J
    Immunology; 1979 Nov; 38(3):641-8. PubMed ID: 521056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte receptors for the Fc portion of IgG are increased in systemic lupus erythematosus.
    Fries LF; Mullins WW; Cho KR; Plotz PH; Frank MM
    J Immunol; 1984 Feb; 132(2):695-700. PubMed ID: 6228597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human anti-streptokinase antibodies induce platelet aggregation in an Fc receptor (CD32) dependent manner.
    Lebrazi J; Helft G; Abdelouahed M; Elalamy I; Mirshahi M; Samama MM; Lecompte T
    Thromb Haemost; 1995 Sep; 74(3):938-42. PubMed ID: 8571325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
    Edberg JC; Wright E; Taylor RP
    J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus.
    Nezlin R; Alarcón-Segovia D; Shoenfeld Y
    J Autoimmun; 1998 Oct; 11(5):489-93. PubMed ID: 9802934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.